Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Watt

Showing results (91-100 of 99) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 99 results.
Diabetes|August 24, 2017
Endothelial SHIP2 Suppresses Nox2 NADPH Oxidase-Dependent Vascular Oxidative Stress, Endothelial Dysfunction, and Systemic Insulin ResistanceNicole T Watt, Matthew C Gage, Peysh A Patel, et al.
American Journal of Physiology. Cell Physiology|May 14, 2020
Divergent effects of genetic and pharmacological inhibition of Nox2 NADPH oxidase on insulin resistance-related vascular damageAzhar Maqbool, Nicole T Watt, Natalie Haywood, et al.
Cardiovascular Research|April 2, 2025
Endothelial insulin-like growth factor-1 signaling regulates vascular barrier function and atherogenesisMichael Drozd, Alexander-Francisco Bruns, Nadira Y Yuldasheva, et al.
The Journal of Clinical Endocrinology and Metabolism|February 25, 2011
Modified-release recombinant human TSH (MRrhTSH) augments the effect of (131)I therapy in benign multinodular goiter: results from a multicenter international, randomized, placebo-controlled studyH Graf, S Fast, F Pacini, et al.
EMBO Reports|May 2, 2021
Endothelial IGF-1 receptor mediates crosstalk with the gut wall to regulate microbiota in obesityNatalie J Haywood, Cheukyau Luk, Katherine I Bridge, et al.
BMC Endocrine Disorders|September 21, 2018
Study protocol: a randomised controlled trial on the clinical effects of levothyroxine treatment for subclinical hypothyroidism in people aged 80 years and overR S Du Puy, I Postmus, D J Stott, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 31, 2013
Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degenerationClotilde Lagier-Tourenne, Michael Baughn, Frank Rigo, et al.
Nature Genetics|May 30, 2018
Analysis of the androgen receptor-regulated lncRNA landscape identifies a role for ARLNC1 in prostate cancer progressionYajia Zhang, Sethuramasundaram Pitchiaya, Marcin Cieślik, et al.
Nature Communications|January 3, 2025
Paracrine role of endothelial IGF-1 receptor in depot-specific adipose tissue adaptation in male miceCheukyau Luk, Katherine I Bridge, Nele Warmke, et al.
Pageof 10

Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
Diabetes|August 24, 2017
Endothelial SHIP2 Suppresses Nox2 NADPH Oxidase-Dependent Vascular Oxidative Stress, Endothelial Dysfunction, and Systemic Insulin ResistanceNicole T Watt, Matthew C Gage, Peysh A Patel, et al.
American Journal of Physiology. Cell Physiology|May 14, 2020
Divergent effects of genetic and pharmacological inhibition of Nox2 NADPH oxidase on insulin resistance-related vascular damageAzhar Maqbool, Nicole T Watt, Natalie Haywood, et al.
Cardiovascular Research|April 2, 2025
Endothelial insulin-like growth factor-1 signaling regulates vascular barrier function and atherogenesisMichael Drozd, Alexander-Francisco Bruns, Nadira Y Yuldasheva, et al.
The Journal of Clinical Endocrinology and Metabolism|February 25, 2011
Modified-release recombinant human TSH (MRrhTSH) augments the effect of (131)I therapy in benign multinodular goiter: results from a multicenter international, randomized, placebo-controlled studyH Graf, S Fast, F Pacini, et al.
EMBO Reports|May 2, 2021
Endothelial IGF-1 receptor mediates crosstalk with the gut wall to regulate microbiota in obesityNatalie J Haywood, Cheukyau Luk, Katherine I Bridge, et al.
BMC Endocrine Disorders|September 21, 2018
Study protocol: a randomised controlled trial on the clinical effects of levothyroxine treatment for subclinical hypothyroidism in people aged 80 years and overR S Du Puy, I Postmus, D J Stott, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 31, 2013
Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degenerationClotilde Lagier-Tourenne, Michael Baughn, Frank Rigo, et al.
Nature Genetics|May 30, 2018
Analysis of the androgen receptor-regulated lncRNA landscape identifies a role for ARLNC1 in prostate cancer progressionYajia Zhang, Sethuramasundaram Pitchiaya, Marcin Cieślik, et al.
Nature Communications|January 3, 2025
Paracrine role of endothelial IGF-1 receptor in depot-specific adipose tissue adaptation in male miceCheukyau Luk, Katherine I Bridge, Nele Warmke, et al.
Pageof 10